Considerations for diagnostic COVID-19 tests

During the early phase of the coronavirus disease 2019 (COVID-19) pandemic, design, development, validation, verification and implementation of diagnostic tests were actively addressed by a large number of diagnostic test manufacturers. Hundreds of molecular tests and immunoassays were rapidly devel...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature reviews. Microbiology 2021-03, Vol.19 (3), p.171-183
Hauptverfasser:	Vandenberg, Olivier, Martiny, Delphine, Rochas, Olivier, van Belkum, Alex, Kozlakidis, Zisis
Format:	Artikel
Sprache:	eng
Schlagworte:	631/326/2521 631/326/596/4130 692/308 Biomedical and Life Sciences Coronaviridae Coronaviruses COVID-19 COVID-19 - diagnosis COVID-19 Testing - economics COVID-19 Testing - methods COVID-19 Testing - standards Developed Countries Developing Countries Diagnostic systems Diagnostic Test Approval Diagnostic tests Humans Immunoassays Infection control Infectious Diseases Life Sciences Manufacturing Industry Medical diagnosis Medical Microbiology Methods Microbiology Outbreaks Pandemics Parasitology Point-of-Care Testing Public health administration Review Review Article SARS-CoV-2 - genetics SARS-CoV-2 - isolation & purification Time Factors Viral diseases Virology World Health Organization
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!